Veradermics, Inc (MANE) — SEC Filings
Veradermics, Inc (MANE) — 5 SEC filings. Latest: EFFECT (Apr 30, 2026). Includes 2 8-K, 1 EFFECT, 1 FWP. AI-decoded analysis.
View Veradermics, Inc on SEC EDGAR
Overview
Veradermics, Inc (MANE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a EFFECT filed on Apr 30, 2026: Veradermics, Inc. filed an EFFECT form on April 30, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001392, relates to Act 33 and File No. 333-295356. The company's mailing and business address is 470 James Street, New Haven, CT 06513.
Sentiment Summary
Across 5 filings, the sentiment breakdown is: 5 neutral. The dominant filing sentiment for Veradermics, Inc is neutral.
Filing Type Overview
Veradermics, Inc (MANE) has filed 1 EFFECT, 1 FWP, 1 S-1MEF, 2 8-K with the SEC between Mar 2026 to Apr 2026.
Recent SEC Filings (5)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 30, 2026 | EFFECT | Veradermics, Inc. EFFECT Filing Effective | low |
| Apr 30, 2026 | FWP | Veradermics Files Free Writing Prospectus | low |
| Apr 30, 2026 | S-1MEF | Veradermics Files S-1MEF for Additional Securities | medium |
| Apr 27, 2026 | 8-K | Veradermics, Inc. Files 8-K Report | low |
| Mar 30, 2026 | 8-K | 8-K Filing |
Risk Profile
Risk Assessment: Of MANE's 4 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 3 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
securities-offering (3) · registration-statement (2) · effectiveness (1) · fwp (1) · prospectus (1) · pharmaceuticals (1) · 8-K (1) · disclosure (1) · exhibits (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| File Number | 333-295356 | Relates to the registration statement |
| Filing Date | 2026-04-30 | Date the FWP was officially filed with the SEC. |
| Accepted Date | 2026-04-29 | Date the SEC accepted the FWP filing. |
| Form Type | S-1MEF | Indicates a registration of additional securities under Rule 462(b) to a prior S-1 filing. |
| Effectiveness Date | 2026-04-29 | The date the registration statement became effective, allowing for the sale of securities. |
Frequently Asked Questions
What are the latest SEC filings for Veradermics, Inc (MANE)?
Veradermics, Inc has 5 recent SEC filings from Mar 2026 to Apr 2026, including 2 8-K, 1 EFFECT, 1 FWP. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MANE filings?
Across 5 filings, the sentiment breakdown is: 5 neutral. The dominant sentiment is neutral.
Where can I find Veradermics, Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Veradermics, Inc (MANE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Veradermics, Inc?
Financial highlights for Veradermics, Inc are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for MANE?
Investment thesis data for MANE will be available once enriched filings are processed.
Who are the key executives at Veradermics, Inc?
Executive information for Veradermics, Inc is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Veradermics, Inc stock?
Of MANE's 4 assessed filings, 0 were flagged high-risk, 1 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Veradermics, Inc?
Forward guidance and predictions for Veradermics, Inc are extracted from SEC filings as they are enriched.